Perspective · 10 Sep 2026
Short communicationPublished 2016
Relationship of Gender, Use of Disease-Modifying Therapies, and Health Insurance in Multiple Sclerosis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Recent findings have demonstrated that use of disease-modifying therapies (DMTs) in persons with multiple sclerosis was affected by health insurance. Many patients relied on free or discounted drug programs for DMT use and when they obtained DMTs through their health insurance, it was not uncommon for them to experience insurance challenges for DMT use. However, it is not known how these findings were associated with gender. Here we investigate the association between gender and (1) DMT use, (2) use of free or discounted drug programs, and (3) insurance challenges for DMT use using participants from North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Guoqiao Wang”
- BylineArticles whose byline prints “Amber R Salter”
